We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IT:NYSEGartner, Inc. Analysis

Data as of 2026-06-13 - not real-time

$148.17

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gartner's stock trades at $148.17, well below its DCF‑derived fair value of $185.1, indicating a discount of roughly 12.7%. The price‑to‑earnings multiple of 14.6 is far beneath the industry average of 36.8, further underscoring undervaluation. However, the 30‑day volatility of over 52% and a decreasing volume trend point to heightened short‑term price swings. Technical indicators are mixed: the 20‑day SMA ($159.3) sits above the current price, while the MACD histogram is negative and the signal line is bearish, suggesting downward momentum. The RSI at 40 signals that the stock is not yet oversold, leaving room for buyers. The company posted a Q1 2026 earnings beat on Insights revenue, adjusted EBITDA and free cash flow, providing a positive earnings momentum.
Management highlighted strong new business with enterprise leaders despite a slowdown in March due to geopolitical factors. A class‑action securities‑fraud lawsuit filed in May adds a material legal headwind that could affect investor sentiment. Gartner’s operating margin of 20.5% and free cash flow generation of $1.06 bn demonstrate robust profitability and cash generation. The balance sheet shows a high debt‑to‑equity ratio driven by substantial cash holdings, resulting in a low net leverage profile. The “Extreme Greed” reading of 89.86 on the fear‑greed index reflects a market environment that may be pricing in optimism. Considering the upside potential, strong fundamentals, and pending legal risk, the stock appears attractive for investors with a medium‑ to long‑term horizon while warranting caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • Class‑action lawsuit creating legal uncertainty
  • High short‑term volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervaluation relative to DCF and industry PE
  • Q1 earnings beat and strong free cash flow
  • Positive outlook for global IT spending growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained high operating margins and ROE
  • Recurring subscription‑based revenue model
  • Low beta and diversified geographic footprint

Key Metrics & Analysis

Financial Health

Revenue Growth-1.50%
Profit Margin11.44%
P/E Ratio14.6
ROE94.88%
ROA9.38%
Debt/Equity5293.41
P/B Ratio158.6
Op. Cash Flow$1.4B
Free Cash Flow$1.1B
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI40.3
Support$141.74
Resistance$180.45
MA 20$159.31
MA 50$154.55
MA 200$202.71
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$185.15
Target Price$167.00
Upside/Downside12.71%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.77
Volatility52.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.